Search the web
Welcome, Guest
[Sign Out, My Account]
EDGAR_Online

Quotes & Info
Enter Symbol(s):
e.g. YHOO, ^DJI
Symbol Lookup | Financial Search
AMED > SEC Filings for AMED > Form 8-K on 19-Mar-2014All Recent SEC Filings

Show all filings for AMEDISYS INC

Form 8-K for AMEDISYS INC


19-Mar-2014

Change in Directors or Principal Officers, Regulation FD Disclosure, Financial State


Item 5.02 Departure of Directors or Certain Officers; Election of Directors;
Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.

On March 18, 2014, the Board approved the appointment, effective March 24, 2014, of Dale E. Redman, age 66, as the Company's Interim Chief Financial Officer. In this capacity, Mr. Redman shall function as the Company's principal financial officer, and it is anticipated that he will continue to serve in such capacity until the Company fills the position of Chief Financial Officer on a permanent basis. Mr. Redman previously served as the Company's Chief Financial Officer from February 2007 through December 2011 and retired from the Company as its Executive Vice President of Finance in February 2012.

Mr. Redman's employment with the Company is on at "at will" basis, and as a temporary employee, he is not eligible to participate in certain Company-sponsored programs, including health and wellness benefits, Company-sponsored incentive plans and the Company's severance plan for senior, non-executive management.

In compensation for his service, as approved by the Compensation Committee of the Board, Mr. Redman will receive a salary equivalent to $400,000 on an annualized basis, payable in accordance with the Company's bi-weekly payroll practices applicable to its full-time, salaried employees. He is eligible to receive a bonus of $150,000 provided he (i) does not resign prior to the date that the Company fills the position of Chief Financial Officer on a permanent basis and (ii) is not terminated for cause. If earned, the bonus is payable on the latter of (i) his last day of employment or (ii) December 31, 2014. As a condition of employment, Mr. Redman executed an agreement with the Company containing protective covenants, indemnification provisions in his favor similar to those provided to the Company's executive officers and a provision requiring all disputes to be submitted to arbitration. The preceding summary of the agreement with Mr. Redman does not purport to be complete and is qualified in its entirety by reference to the agreement, a copy of which is attached hereto as Exhibit 99.1 and is incorporated herein by reference.

Following his retirement from the Company until his appointment as Interim Chief Financial Officer, Mr. Redman managed personal investments. Prior to February 2007, Mr. Redman served as Managing Director at Windward Capital Consulting, LLC, where he assisted businesses with capital structure issues and provided management consulting services in support of such companies' growth strategies. Prior to April 1999, he was the Executive Vice President and Chief Financial Officer of United Companies Financial Corporation, which was a publicly-traded home mortgage and home equity lender based in Baton Rouge, Louisiana. He graduated from Louisiana State University with a Masters Degree in Accounting.



Item 7.01. Regulation FD Disclosure.

On March 19, 2014, the Company issued a press release titled "Amedisys Announces Appointment of Dale E. Redman as Interim Chief Financial Officer," a copy of which is furnished herewith as Exhibit 99.2 to this Current Report on Form 8-K.

The information presented in Item 7.01 of this Current Report on Form 8-K and Exhibit 99.2 attached hereto shall not be deemed "filed" for purposes of
Section 18 of the Securities Exchange Act of 1934, as amended (the "Exchange Act"), or otherwise subject to the liabilities of that section, unless the Company specifically states that the information is to be considered "filed" under the Exchange Act or specifically incorporates it by reference in any filing under the Securities Act of 1933, as amended, or the Exchange Act.




Item 9.01. Financial Statements and Exhibits.

(d) Exhibits.

99.1    Agreement by and among Amedisys, Inc., Amedisys Holding, L.L.C. and Dale.
        E. Redman dated as of March 24, 2014

99.2    Press Release dated March 19, 2014 titled "Amedisys Announces Appointment
        of Dale E. Redman as Interim Chief Financial Officer"

  Add AMED to Portfolio     Set Alert         Email to a Friend  
Get SEC Filings for Another Symbol: Symbol Lookup
Quotes & Info for AMED - All Recent SEC Filings
Copyright © 2014 Yahoo! Inc. All rights reserved. Privacy Policy - Terms of Service
SEC Filing data and information provided by EDGAR Online, Inc. (1-800-416-6651). All information provided "as is" for informational purposes only, not intended for trading purposes or advice. Neither Yahoo! nor any of independent providers is liable for any informational errors, incompleteness, or delays, or for any actions taken in reliance on information contained herein. By accessing the Yahoo! site, you agree not to redistribute the information found therein.